๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of panic disorder treatments on personality disorder characteristics

โœ Scribed by Stefan G. Hofmann; M. Katherine Shear; David H. Barlow; Jack M. Gorman; David Hershberger; Marcus Patterson; Scott W. Woods


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
68 KB
Volume
8
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

โœฆ Synopsis


Ninety-three patients with panic disorder and mild or no agoraphobia were treated for their panic disorder by using either 11 sessions of individual cognitive-behavior therapy or imipramine. Before and after treatment, their panic disorder symptomatology was assessed, and a self-report measure was administered to measure personality disorder characteristics 8:14-20, 1998.

: Wisconsin Personality Disorders Inventory]. In addition, some patients received this personality assessment again after six monthly maintenance sessions. Both treatments were equally effective in reducing panic disorder symptomatology, and both treatments had a positive influence on personality disorder characteristics. Personality disorder characteristics did not predict treatment outcome in either group. The implications of the findings for the assessment of personality and the treatment of panic disorder are discussed. Depression and Anxiety


๐Ÿ“œ SIMILAR VOLUMES


SSRIs in the treatment of panic disorder
โœ Andrew W. Goddard; Dennis S. Charney ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB ๐Ÿ‘ 2 views
Ondansetron in the treatment of panic di
โœ Franklin R. Schneier; Robin Garfinkel; Barbara Kennedy; Raphael Campeas; Brian F ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 362 KB ๐Ÿ‘ 2 views
Parent-of-origin effect in panic disorde
โœ Haghighi, Fatemeh; Fyer, Abby J.; Weissman, Myrna M.; Knowles, James A.; Hodge, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 17 KB ๐Ÿ‘ 2 views

Parent-of-origin effect was examined in a series of 64 pedigrees with panic disorder (PD) under both the narrow and broad diagnostic models. The narrow diagnostic model defined the affected phenotype to include only the ''definite'' and ''probable'' forms of PD, whereas the broad diagnostic model in

Setting New Standards for the Pharmacolo
โœ R. KUMAR ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 161 KB ๐Ÿ‘ 1 views

Three drugs are currently licensed for the treatment of panic disorder: the benzodiazepine, alprazolam; the tricyclic antidepressant, clomipramine; and, most recently, the selective serotonin reuptake inhibitor, paroxetine. Alprazolam and clomipramine are eective in the treatment of panic disorder,